The recombinant IgA1-P has been shown to markedly reduce IgA1 in the serum and IgA1 deposits in the mesangium, and mitigate inflammation, fibrosis, and hematuria in the α1KI-CD89Tg mouse model of IgAN 166. Here, IGHA1 is linked to Hematuria.